Upper urinary tract transitional cell carcinoma after total cystectomy for bladder cancer

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• Transitional cell carcinoma (TCC) is the most common type of bladder cancer.
• Radical cystectomy is a standard treatment for invasive bladder cancer.
• Multifocal, low-stage TCC in the bladder may indicate a higher risk for upper tract recurrence.

Observation:

• A 17-year study (1967-1983) analyzed 110 patients undergoing cystectomy for TCC.
• Seven patients (6.4%) developed upper urinary tract urothelial cancer post-cystectomy.
• The latency period ranged from under three months to nearly 13 years.

Findings:

• All patients with upper tract tumors had multifocal, low-stage TCC in the original bladder specimen.
• Malignant conduit urine cytology was the initial sign in five patients; hematuria in two.
• One patient presented with bilateral renal pelvic tumors; five patients underwent surgical treatment.

Implications:

• Regular, frequent urine cytology screening is essential for patients with multifocal, low-stage TCC.
• Early detection of upper tract urothelial cancer improves treatment outcomes.
• This highlights the systemic nature of urothelial neoplasia and the need for lifelong surveillance.